ProMIS Neurosciences
Price & Volume
Stats
See more52W Range | $6.27-$27.40 |
Market Cap | $84.7M |
Shares Short | 238,584 |
Financials
See moreRevenue (12 Mos) | $7,558 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$35.6M |
Diluted EPS | -$11.65 |
News
See moreYahoo Finance • 3 months ago
AI concerns pressure chipmakers premarket; UPS, Carrier rise
Yahoo Finance • 3 months ago
ProMIS Neurosciences Reports Positive Blinded Six-Month Interim Safety and Biomarker Data for PMN310 in the PRECISE-AD Phase 1b Alzheimer’s Disease Trial
Yahoo Finance • 3 months ago
Can Higher Occupancy Offset Lower Admissions in CYH's Q2 Earnings?
Yahoo Finance • 3 months ago
ProMIS Reports First Human PMN310 Target Engagement In Alzheimer's Disease; Stock Up
About
CEO | Mr. Neil K. Warma M.B.A. |
Address | 1920 Yonge Street, Toronto, ON, Canada, M4S 3E2 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 10 |